Cargando…

Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications

Memantine is a noncompetitive moderate‐affinity strong voltage‐dependent N‐methyl‐D‐aspartate receptor antagonist. It has been used to treat Alzheimer's disease (AD) since 1989. In 2018, it became the second most commonly used drug for the treatment of dementia in the world. AD is nonreversible...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bin‐Can, Wang, Ya‐Ting, Ren, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527776/
https://www.ncbi.nlm.nih.gov/pubmed/37786758
http://dx.doi.org/10.1002/ibra.12098